Area of research
Molecular Biology · Immunology
Research interest
Research focused on Gene knockdown and Cancer research, with related work in Percutaneous coronary intervention, Autophagy, PI3K/AKT/mTOR pathway. Notable publications include 'Epitaxial Growth of Vertically Aligned Antimony Selenide Nanorod Arrays for Heterostructure Based Self‐Powered Photodetector', 'The association of metabolic syndrome components and chronic kidney disease in patients with hypertension', and 'PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway'.
Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention
Epitaxial Growth of Vertically Aligned Antimony Selenide Nanorod Arrays for Heterostructure Based Self‐Powered Photodetector
PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway
Regulator of cullins-1 (ROC1) negatively regulates the Gli2 regulator SUFU to activate the hedgehog pathway in bladder cancer
The Effect of Adiponectin Via Regulating the Bone Microenvironment Oxidative Stress on Osteogenesis in Type 2 Diabetic Rats
The role of non-coding RNA network in atherosclerosis
Effectiveness of Levoamlodipine Maleate for Hypertension Compared with Amlodipine Besylate: a Pragmatic Comparative Effectiveness Study
The association of metabolic syndrome components and chronic kidney disease in patients with hypertension
Rac3, but not Rac1, promotes ox‐LDL induced endothelial dysfunction by downregulating autophagy
Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention
Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway
Five-year outcomes of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with biodegradable polymer-coated sirolimus-eluting stents: Insights from the CREATE trial
Chinese expert consensus on the management of hypertension in the very elderly.